Insider Transactions in Q2 2021 at Lineage Cell Therapeutics, Inc. (LCTX)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 30
2021
|
Brian M Culley President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,343
-8.74%
|
$10,686
$2.85 P/Share
|
Jun 30
2021
|
Brian M Culley President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,450
+20.17%
|
$30,900
$2.85 P/Share
|
Jun 29
2021
|
Angus C. Russell |
SELL
Open market or private sale
|
Direct |
4,720
-5.12%
|
$9,440
$2.97 P/Share
|
Jun 29
2021
|
Angus C. Russell |
BUY
Exercise of conversion of derivative security
|
Direct |
24,720
+21.14%
|
$49,440
$2.2 P/Share
|
Jun 29
2021
|
Deborah J Andrews |
SELL
Open market or private sale
|
Direct |
19,142
-55.13%
|
$38,284
$2.93 P/Share
|
Jun 29
2021
|
Deborah J Andrews |
BUY
Exercise of conversion of derivative security
|
Direct |
24,720
+41.59%
|
$49,440
$2.2 P/Share
|
Jun 28
2021
|
Brian M Culley President and CEO |
SELL
Open market or private sale
|
Direct |
450,000
-90.78%
|
$900,000
$2.87 P/Share
|
Jun 28
2021
|
Brian M Culley President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
300,000
+37.7%
|
$0
$0.69 P/Share
|
Jun 25
2021
|
Neal C Bradsher Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,720
+22.0%
|
$49,440
$2.2 P/Share
|
Jun 22
2021
|
Alfred D Kingsley Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
61,800
+1.12%
|
$123,600
$2.2 P/Share
|
Jun 18
2021
|
Michael H. Mulroy |
BUY
Exercise of conversion of derivative security
|
Direct |
24,720
+8.95%
|
$49,440
$2.2 P/Share
|